SRT6
SRT6 is an anti-cancer agent and functions as a CD44 inhibitor. It blocks essential CD44-related kinases, including SRC, ERBB2, and MAPKAPK2. SRT6 exhibits significant tumor selectivity and possesses notable antiproliferative activity against cancer cells (with an EC50 of 1.37 μM for NCI-H23 cells) .
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog